Jeff Yass’s Prime Medicine PRME Stock Holding History
Bought
Maintained
Sold
Other funds holding PRME
Jeff Yass's PRME Position: Q3 2026 in Review
Jeff Yass increased its Prime Medicine (PRME) stake by 6.3% in Q3 2026, buying an estimated $135K and bringing the position to 689,157 shares worth $2.11M. The position accounts for ﹤0.01% of the portfolio, ranked #6147.
Jeff Yass first reported a position in PRME in Q2 2023 and has held it in 13 quarters since. The position peaked at $4.08M in Q4 2025. 185 funds tracked by Wall St. Rank hold PRME as of Q3 2026.
- Jeff Yass held 689,157 shares of Prime Medicine worth $2.11M as of Q3 2026.
- Jeff Yass bought 40,678 Prime Medicine shares in Q3 2026, an estimated $135K.
- Prime Medicine made up ﹤0.01% of Jeff Yass's portfolio in Q3 2026, its #6147 holding.
- Jeff Yass first reported a position in Prime Medicine in Q2 2023 and has held it in 13 quarters since.
- Jeff Yass's Prime Medicine position peaked at $4.08M in Q4 2025.
- 185 funds tracked by Wall St. Rank held Prime Medicine as of Q3 2026.
Based on Susquehanna International Group's 13F filing for Q3 2026, filed 16 Nov 2026.